Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (vol, pg, 2019)

被引：4
|
作者：
Xu, Jiangsheng
Liu, Yunhua
Li, Yujing
Wang, Hai
Stewart, Samantha
Van der Jeught, Kevin
Agarwal, Pranay
Zhang, Yuntian
Liu, Sheng
Zhao, Gang
Wan, Jun
Lu, Xiongbin
He, Xiaoming
机构：
[1] University of Maryland,Fischell Department of Bioengineering
[2] The Ohio State University,Comprehensive Cancer Centre
[3] The Ohio State University,Department of Biomedical Engineering
[4] Indiana University School of Medicine,Department of Medical and Molecular Genetics
[5] Indiana University School of Medicine,Melvin and Bren Simon Cancer Centre
[6] University of Science and Technology of China,Department of Electronics Science and Technology
[7] University of Maryland,Robert E. Fischell Institute for Biomedical Devices
[8] University of Maryland,Marlene and Stewart Greenebaum Comprehensive Cancer Centre
来源：
NATURE NANOTECHNOLOGY | 2020年 / 15卷 / 04期
关键词：
D O I：
10.1038/s41565-020-0635-3
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [41] Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer
    Shettigar, Anusha
    Salunke, Rushigandha
    Modi, Deepak
    Mukherjee, Nupur
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [42] Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy
    Dheeraj, Arpit
    Marques, Fernando Jose Garcia
    Tailor, Dhanir
    Bermudez, Abel
    Resendez, Angel
    Pandrala, Mallesh
    Grau, Benedikt
    Kumar, Praveen
    Haley, Carrsyn B.
    Honkala, Alexander
    Kujur, Praveen
    Jeffrey, Stefanie S.
    Pitteri, Sharon
    V. Malhotra, Sanjay
    CELL REPORTS MEDICINE, 2024, 5 (05)
  • [43] From molecular insight to therapeutic strategy: The holistic approach for treating triple negative breast cancer
    Bhattacharya, Rittwika
    Banerjee, Koyel
    Mukherjee, Nupur
    Sen, Minakshi
    Mukhopadhyay, Ashis
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (03) : 177 - 182
  • [44] Targeting of breast cancer with non-oncology drugs - possible novel therapeutic option for triple-negative breast cancer
    Liedtke, C.
    Yan, K.
    Wu, Y.
    Hortobagyi, G. N.
    Symmans, W. F.
    Valero, V.
    Goette, M.
    Kiesel, L.
    Pusztai, L.
    CANCER RESEARCH, 2009, 69 (02) : 192S - 192S
  • [45] Differential Targeting of the RB-Pathway To Expand the Therapeutic Index in the Treatment of Triple Negative Breast Cancer
    Knudsen, E. S.
    Dean, J.
    Thangavel, C.
    Ertel, A.
    Witkiewicz, A. K.
    McClendon, A. K.
    CANCER RESEARCH, 2011, 71
  • [46] Therapeutic targeting of bromodomain and extra-terminal proteins degradation in triple-negative breast cancer
    Bai, Longchuan
    Zhou, Bing
    Yang, Chao-Yie
    Ji, Jiao
    McEachern, Donna
    Przybranowski, Sally
    Wang, Shaomeng
    CANCER RESEARCH, 2017, 77
  • [47] Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer
    Ndinguri, Margaret
    Middleton, Lisa
    Unrine, Jason
    Lui, Shu
    Rollins, Joseph
    Nienaber, Emma
    Spease, Cassidy
    Williams, Aggie
    Cormier, Lindsay
    PLOS ONE, 2023, 18 (10):
  • [48] Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
    Quereda, Victor
    Bayle, Simon
    Vena, Francesca
    Frydman, Sylvia M.
    Monastyrskyi, Andrii
    Roush, William R.
    Duckett, Derek R.
    CANCER CELL, 2019, 36 (05) : 545 - +
  • [49] Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
    Canonici, Alexandra
    Browne, Alacoque L.
    Ibrahim, Mohamed F. K.
    Fanning, Kevin P.
    Roche, Sandra
    Conlon, Neil T.
    O'Neill, Fiona
    Meiller, Justine
    Cremona, Mattia
    Morgan, Clare
    Hennessy, Bryan T.
    Eustace, Alex J.
    Solca, Flavio
    O'Donovan, Norma
    Crown, John
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [50] Therapeutic utility of EC359 for targeting oncogenic LIFR signaling in triple negative breast cancer
    Viswanadhapalli, Suryavathi
    Li, Mengxing
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Santhamma, Bindu
    Zhou, Mei
    Ma, Shihong
    Sonavane, Rajni
    Pratap, Uday P.
    Altwegg, Kristin A.
    Chang, Annabel
    Chavez-Riveros, Alejandra
    Dileep, Kalarickal V.
    Zhang, Kam Y.
    Bajda, Marek
    Raj, Ganesh V.
    Brenner, Andrew
    Manthati, Vijaya
    Rao, Manjeet
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2019, 79 (13)
12345